Dialysis - Granuflo & Naturalyte
Finkelstein & Partners is currently investigating cases involving Dialysis Products Granuflo and Naturalyte. These products, manufactured by Fresenius have been connected to an increased risk of cardiopulmonary arrest and sudden cardiac death. In March 2012, Fresenius issued an Urgent Product Notification warning its customers that GranuFlo and NaturaLyte are associated with elevated bicarbonate levels, a significant risk factor for cardiac arrest.The company failed to warn patients and doctors of the possible side effects of using these products until 2012. According to a November 4th memo, 941 patients who died at Fresenius dialysis centers in 2010 were found to have elevated levels of bicarbonate in their blood. Bicarbonate overdose risk in patients include low blood pressure, heart attack, heart problems, Cardio pulmonary arrest, Metabolic alkalosis, stroke and even death.
If you or someone you know used Granuflo or Naturalyte and suffered one of these conditions please contact us right away.